CD4-depleted mice treated with SQV + DMBA (12/18) had a statistically significant increase in tumor-free survival as compared to the CD4-depleted DMBA-treated mice (15/18) (p-value = 0.0255) (Figure 2 with numbers shown in Table 2). The gene discussed is CD4; the disease is neoplasm.